<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02636413</url>
  </required_header>
  <id_info>
    <org_study_id>VPH-GXL-2013-01</org_study_id>
    <secondary_id>2015-001181-26</secondary_id>
    <nct_id>NCT02636413</nct_id>
  </id_info>
  <brief_title>Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance</brief_title>
  <official_title>Evaluation of the Impact of LacTEST on Diagnostic Thinking and on Patient Management, and of the Reproducibility (Test-Retest), for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VenterPharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VenterPharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate both the impact of LacTEST on diagnostic thinking
      and on patient management, and its reproducibility (Test-Retest), for the diagnosis of
      hypolactasia in adults and elderly patients presenting with clinical symptoms of lactose
      intolerance.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogical Scale</measure>
    <time_frame>Through study completion, up to 10 months.</time_frame>
    <description>The primary objective is to demonstrate non-inferiority of gaxilose test, compared with Hydrogen Breath Test (HBT) using a validated method (VAS results pre and post-test), on the impact on diagnostic thinking for the diagnosis of hypolactasia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physician's Questionnaire</measure>
    <time_frame>Through study completion, up to 10 months.</time_frame>
    <description>To demonstrate non-inferiority of gaxilose test, compared with Hydrogen Breath Test (HBT), on the impact on patient management for the diagnosis of hypolactasia, through a Physician's Qestionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraclass Correlation Coefficient</measure>
    <time_frame>Through study completion, up to 10 months.</time_frame>
    <description>To demonstrate gaxilose test reproducibility [ICC (2,1)] with urine accumulated from 0-4h after gaxilose administration, and with urine accumulated from 0-5h after gaxilose administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by the most recent version of MedDRA thesaurus.</measure>
    <time_frame>Through study completion, up to 10 months.</time_frame>
    <description>To assess the safety profile of both tests performed, by assessing the frecuency of treatment-related AEs.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Lactose Intolerance</condition>
  <arm_group>
    <arm_group_label>LacTEST</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0,45 g of gaxilose po, once, per diagnostic test performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrogen Breath Test</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 to 50 g of lactose po, once, per diagnostic test performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gaxilose</intervention_name>
    <description>After gaxilose administration, urine collection, cuantification (firstly from 0 to 4 hours, and total urine from 0 to 5 hours), and xilose cuantification afterwards.</description>
    <arm_group_label>LacTEST</arm_group_label>
    <other_name>LacTEST</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>lactose</intervention_name>
    <description>After lactose administration, expired hydrogen measurement at pre-specified intervals.</description>
    <arm_group_label>Hydrogen Breath Test</arm_group_label>
    <other_name>Hydrogen Breath Test (HBT)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adults of either sex, between 18 and 70 years old.

          2. Capacity for understanding and giving the informed consent to participate in this
             study.

          3. Patients with clinical suggestive of lactose intolerance, primary or secondary, who
             have not been diagnosed and that fulfil the requirements allowed by the gaxilose
             summary of product characteristics (SmPC).

        Exclusion Criteria:

          1. Pregnant women or breast-feeding women.

          2. Unable or reticent to give the informed consent or to comply with the study
             requirements.

          3. Patients with glomerular filtration rate (GFR) less than 90 ml/min/1.73m2.

          4. Portal hypertension: ascites, cirrhosis.

          5. Medical records of total gastrectomy and/or vagotomy.

          6. Patients diagnosed with myxedema.

          7. Patients with Diabetes Mellitus.

          8. Patients who are participating or have participated in any clinical trial within the 3
             months previous to their inclusion in the study.

          9. Patients who are drug abuse consumers.

         10. Patients under treatment with antibiotics, sulphamides and antiparasitics, who cannot
             suspend the treatments 7 days prior to the performance of the hydrogen breath test.

         11. Patients with any recognized and already existing disorder that might interfere with
             the any of the lactose intolerance diagnosis tests.

         12. Patients who have taken aspirin of indomethacin in the 48h preceding the performance
             of the Gaxilose test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Crespo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Ramón y Cajal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Getafe</name>
      <address>
        <city>Getafe</city>
        <state>Madrid</state>
        <zip>28905</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Doctor Josep Trueta</name>
      <address>
        <city>Girona</city>
        <zip>17007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de La Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Aragón JJ, Hermida C, Martínez-Costa OH, Sánchez V, Martín I, Sánchez JJ, Codoceo R, Cano JM, Cano A, Crespo L, Torres Y, García FJ, Fernández-Mayoralas A, Solera J, Martínez P. Noninvasive diagnosis of hypolactasia with 4-Galactosylxylose (Gaxilose): a multicentre, open-label, phase IIB-III nonrandomized trial. J Clin Gastroenterol. 2014 Jan;48(1):29-36. doi: 10.1097/MCG.0b013e318297fb10.</citation>
    <PMID>23722657</PMID>
  </reference>
  <reference>
    <citation>Chinn S. Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax. 1991 Jun;46(6):454-6. Review.</citation>
    <PMID>1858087</PMID>
  </reference>
  <reference>
    <citation>Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977 Jun;33(2):363-74.</citation>
    <PMID>884196</PMID>
  </reference>
  <reference>
    <citation>Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol Suppl. 1994;202:7-20. Review.</citation>
    <PMID>8042019</PMID>
  </reference>
  <reference>
    <citation>Villako K, Maaroos H. Clinical picture of hypolactasia and lactose intolerance. Scand J Gastroenterol Suppl. 1994;202:36-54. Review.</citation>
    <PMID>8042017</PMID>
  </reference>
  <reference>
    <citation>Suchy FJ, Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB, Hall K, Hui SL, Lupton J, Mennella J, Miller NJ, Osganian SK, Sellmeyer DE, Wolf MA. NIH consensus development conference statement: Lactose intolerance and health. NIH Consens State Sci Statements. 2010 Feb 24;27(2):1-27. Review.</citation>
    <PMID>20186234</PMID>
  </reference>
  <reference>
    <citation>Newcomer AD, McGill DB, Thomas PJ, Hofmann AF. Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med. 1975 Dec 11;293(24):1232-6.</citation>
    <PMID>1186802</PMID>
  </reference>
  <reference>
    <citation>Jellema P, Schellevis FG, van der Windt DA, Kneepkens CM, van der Horst HE. Lactose malabsorption and intolerance: a systematic review on the diagnostic value of gastrointestinal symptoms and self-reported milk intolerance. QJM. 2010 Aug;103(8):555-72. doi: 10.1093/qjmed/hcq082. Epub 2010 Jun 3. Review.</citation>
    <PMID>20522486</PMID>
  </reference>
  <reference>
    <citation>Shaukat A, Levitt MD, Taylor BC, MacDonald R, Shamliyan TA, Kane RL, Wilt TJ. Systematic review: effective management strategies for lactose intolerance. Ann Intern Med. 2010 Jun 15;152(12):797-803. doi: 10.7326/0003-4819-152-12-201006150-00241. Epub 2010 Apr 19. Review.</citation>
    <PMID>20404262</PMID>
  </reference>
  <reference>
    <citation>Newcomer AD, McGill DB. Distribution of disaccharidase activity in the small bowel of normal and lactase-deficient subjects. Gastroenterology. 1966 Oct;51(4):481-8.</citation>
    <PMID>5922947</PMID>
  </reference>
  <reference>
    <citation>Hovde Ø, Farup PG. A comparison of diagnostic tests for lactose malabsorption--which one is the best? BMC Gastroenterol. 2009 Oct 31;9:82. doi: 10.1186/1471-230X-9-82.</citation>
    <PMID>19878587</PMID>
  </reference>
  <reference>
    <citation>Arola H. Diagnosis of hypolactasia and lactose malabsorption. Scand J Gastroenterol Suppl. 1994;202:26-35. Review.</citation>
    <PMID>8042016</PMID>
  </reference>
  <reference>
    <citation>Aragón JJ, Cañada FJ, Fernández-Mayoralas A, López R, Martín-Lomas M, Villanueva D. A direct enzymatic synthesis of beta-D-galactopyranosyl-D-xylopyranosides and their use to evaluate rat intestinal lactase activity in vivo. Carbohydr Res. 1996 Sep 2;290(2):209-16.</citation>
    <PMID>8823908</PMID>
  </reference>
  <reference>
    <citation>Hermida C, Corrales G, Cañada FJ, Aragón JJ, Fernández-Mayoralas A. Optimizing the enzymatic synthesis of beta-D-galactopyranosyl-D-xyloses for their use in the evaluation of lactase activity in vivo. Bioorg Med Chem. 2007 Jul 15;15(14):4836-40. Epub 2007 May 6.</citation>
    <PMID>17512743</PMID>
  </reference>
  <reference>
    <citation>Hermida C, Guerra P, Martínez-Costa OH, Sánchez V, Sánchez JJ, Solera J, Fernández-Mayoralas A, Codoceo R, Frías J, Aragón JJ. Phase I and phase IB clinical trials for the noninvasive evaluation of intestinal lactase with 4-galactosylxylose (gaxilose). J Clin Gastroenterol. 2013 Jul;47(6):501-8. doi: 10.1097/MCG.0b013e318272f507.</citation>
    <PMID>23328304</PMID>
  </reference>
  <reference>
    <citation>Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med. 2006 Jun 6;144(11):850-5.</citation>
    <PMID>16754927</PMID>
  </reference>
  <reference>
    <citation>Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991 Apr-Jun;11(2):88-94.</citation>
    <PMID>1907710</PMID>
  </reference>
  <reference>
    <citation>Lijmer JG, Leeflang M, Bossuyt PM. Proposals for a phased evaluation of medical tests. Med Decis Making. 2009 Sep-Oct;29(5):E13-21. doi: 10.1177/0272989X09336144. Epub 2009 Jul 15.</citation>
    <PMID>19605881</PMID>
  </reference>
  <reference>
    <citation>Van den Bruel A, Cleemput I, Aertgeerts B, Ramaekers D, Buntinx F. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. J Clin Epidemiol. 2007 Nov;60(11):1116-22. Epub 2007 Aug 29. Review.</citation>
    <PMID>17938052</PMID>
  </reference>
  <reference>
    <citation>Blanchard TK, Mackenzie R, Bearcroft PW, Sinnatamby R, Gray A, Lomas DJ, Constant CR, Dixon AK. Magnetic resonance imaging of the shoulder: assessment of effectiveness. Clin Radiol. 1997 May;52(5):363-8.</citation>
    <PMID>9171790</PMID>
  </reference>
  <reference>
    <citation>Stanko LK, Jacobsohn E, Tam JW, De Wet CJ, Avidan M. Transthoracic echocardiography: impact on diagnosis and management in tertiary care intensive care units. Anaesth Intensive Care. 2005 Aug;33(4):492-6.</citation>
    <PMID>16119491</PMID>
  </reference>
  <reference>
    <citation>Blaivas M, Kuhn W, Reynolds B, Brannam L. Change in differential diagnosis and patient management with the use of portable ultrasound in a remote setting. Wilderness Environ Med. 2005 Spring;16(1):38-41.</citation>
    <PMID>15813146</PMID>
  </reference>
  <reference>
    <citation>Hobby JL, Dixon AK, Bearcroft PW, Tom BD, Lomas DJ, Rushton N, Matthewson MH. MR imaging of the wrist: effect on clinical diagnosis and patient care. Radiology. 2001 Sep;220(3):589-93.</citation>
    <PMID>11526253</PMID>
  </reference>
  <reference>
    <citation>Wilt TJ, Shaukat A, Shamliyan T, Taylor BC, MacDonald R, Tacklind J, Rutks I, Schwarzenberg SJ, Kane RL, Levitt M. Lactose intolerance and health. Evid Rep Technol Assess (Full Rep). 2010 Feb;(192):1-410. Review.</citation>
    <PMID>20629478</PMID>
  </reference>
  <reference>
    <citation>Srinivasan U, Jones E, Weir DG, Feighery C. Lactase enzyme, detected immunohistochemically, is lost in active celiac disease, but unaffected by oats challenge. Am J Gastroenterol. 1999 Oct;94(10):2936-41.</citation>
    <PMID>10520848</PMID>
  </reference>
  <reference>
    <citation>Phillips AD, Avigad S, Sacks J, Rice SJ, France NE, Walker-Smith JA. Microvillous surface area in secondary disaccharidase deficiency. Gut. 1980 Jan;21(1):44-8.</citation>
    <PMID>7364319</PMID>
  </reference>
  <reference>
    <citation>Kaufman SS, Lyden ER, Brown CR, Iverson AK, Davis CK, Sudan DL, Fox IJ, Horslen SP, Shaw BW Jr, Langnas AN. Disaccharidase activities and fat assimilation in pediatric patients after intestinal transplantation. Transplantation. 2000 Feb 15;69(3):362-5.</citation>
    <PMID>10706043</PMID>
  </reference>
  <reference>
    <citation>Kirschner BS, DeFavaro MV, Jensen W. Lactose malabsorption in children and adolescents with inflammatory bowel disease. Gastroenterology. 1981 Nov;81(5):829-32.</citation>
    <PMID>6895202</PMID>
  </reference>
  <reference>
    <citation>Van Biervliet S, Eggermont E, Carchon H, Veereman G, Deboeck K. Small intestinal brush border enzymes in cystic fibrosis. Acta Gastroenterol Belg. 1999 Jul-Sep;62(3):267-71.</citation>
    <PMID>10547891</PMID>
  </reference>
  <reference>
    <citation>Parnes HL, Fung E, Schiffer CA. Chemotherapy-induced lactose intolerance in adults. Cancer. 1994 Sep 1;74(5):1629-33.</citation>
    <PMID>8062196</PMID>
  </reference>
  <reference>
    <citation>Bond JH, Levitt MD. Quantitative measurement of lactose absorption. Gastroenterology. 1976 Jun;70(6):1058-62.</citation>
    <PMID>1269865</PMID>
  </reference>
  <reference>
    <citation>Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol. 1978 Jul;6(1):15-24.</citation>
    <PMID>666944</PMID>
  </reference>
  <reference>
    <citation>Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990 Aug;13(4):227-36. Review.</citation>
    <PMID>2197679</PMID>
  </reference>
  <reference>
    <citation>Hobby JL, Tom BD, Todd C, Bearcroft PW, Dixon AK. Communication of doubt and certainty in radiological reports. Br J Radiol. 2000 Sep;73(873):999-1001.</citation>
    <PMID>11064655</PMID>
  </reference>
  <reference>
    <citation>Dixon AK. The impact of medical imaging on the physician's diagnostic and therapeutic thinking. Eur Radiol. 1998;8(3):488-90.</citation>
    <PMID>9510594</PMID>
  </reference>
  <reference>
    <citation>Mackenzie R, Dixon AK, Keene GS, Hollingworth W, Lomas DJ, Villar RN. Magnetic resonance imaging of the knee: assessment of effectiveness. Clin Radiol. 1996 Apr;51(4):245-50.</citation>
    <PMID>8617035</PMID>
  </reference>
  <reference>
    <citation>Pitkänen E. The conversion of D-xylose into D-threitol in patients without liver disease and in patients with portal liver cirrhosis. Clin Chim Acta. 1977 Oct 1;80(1):49-54.</citation>
    <PMID>908147</PMID>
  </reference>
  <reference>
    <citation>CRANE RK. Intestinal absorption of sugars. Physiol Rev. 1960 Oct;40:789-825.</citation>
    <PMID>13696269</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2015</study_first_submitted>
  <study_first_submitted_qc>December 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2015</study_first_posted>
  <last_update_submitted>December 27, 2016</last_update_submitted>
  <last_update_submitted_qc>December 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>November 17, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

